WuXi Biologics
Offering End-to-End Solutions
The WuXi XDC ADC/bioconjugate Drug Product (DP) GMP manufacturing processes include compounding, sterile filtration, filling, lyophilization, stoppering, capping, external washing and visual inspection. The filling line contains a fully isolated, automated aseptic system which can fill liquid and lyophilized products in vial sizes of 2R to 50R.
Vial size (mL) | Filling speed (vials/hr) |
6 hrs forecasted output (Liquid) | Lyophilizer (5 sqm) Capacity (vials/batch) |
Lyophilizer (20 sqm) Capacity (vials/batch) |
2 | 4,200 | 25,200 | 21,000 | 86,372 |
6 | 3,600 | 21,600 | 11,000 | 44,968 |
10 | 3,600 | 21,600 | 9,600 | 37,950 |
20 | 3,000 | 18,000 | 6,000 | 24,200 |
50 | 2,000 | 12,000 | 3,000 | 13,310 |